Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | REGN | AMGN | VRTX | GSK | BMY |
| Company | Regeneron Pharmaceuticals | Amgen Inc | Vertex Pharmaceutic | Gsk Plc ADR | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NYSE |
| Open | 1,014.81 | 301.29 | 478.00 | 41.36 | 43.09 |
| High | 1,017.34 | 303.54 | 481.71 | 41.38 | 43.19 |
| Low | 1,009.15 | 300.76 | 475.52 | 40.97 | 42.22 |
| Last | 1,014.96 | 300.01 | 477.75 | 41.06 | 42.53 |
| Change | +4.42 | -0.69 | -3.78 | -0.03 | -0.49 |
| % Change | +0.44% | -0.23% | -0.78% | -0.06% | -1.14% |
| Volume | 72,077 | 232,403 | 303,663 | 705,763 | 2,762,842 |
| 20-Day Average Volume | 378,798 | 2,221,109 | 1,187,584 | 4,099,299 | 14,361,927 |
| Previous Close | 1,010.54 | 300.70 | 481.53 | 41.06 | 43.02 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 988.32 | 307.05 | 459.65 | 43.42 | 42.03 |
| 20-Day Raw Stochastic | 93.36% | 25.05% | 86.31% | 10.25% | 45.53% |
| 20-Day Relative Strength | 64.54% | 52.73% | 70.15% | 40.92% | 42.04% |
| Weighted Alpha | +31.68 | +28.01 | +42.72 | +15.26 | -36.42 |
| Today's Opinion | 88% Buy | 88% Buy | 100% Buy | 40% Buy | 88% Sell |
| Previous Opinion | 88% Buy | 88% Buy | 100% Buy | 40% Buy | 88% Sell |
| Last Month's Opinion | 72% Buy | 56% Buy | 56% Buy | 88% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.71% since 06/05/24 | -1.75% since 06/05/24 | -0.94% since 06/05/24 | -2.16% since 06/05/24 | +2.58% since 06/05/24 |
| Low | 992.22 on 06/10/24 | 299.80 on 06/11/24 | 475.52 on 06/12/24 | 40.89 on 06/11/24 | 40.70 on 06/06/24 |
| High | 1,017.34 on 06/12/24 | 310.01 on 06/06/24 | 486.42 on 06/07/24 | 42.00 on 06/06/24 | 43.11 on 06/12/24 |
| 1-Month | |||||
| %Chg | +4.03% since 05/10/24 | -2.63% since 05/10/24 | +13.18% since 05/10/24 | -8.89% since 05/10/24 | -5.86% since 05/10/24 |
| Low | 952.30 on 05/30/24 | 295.49 on 05/30/24 | 422.44 on 05/14/24 | 40.51 on 06/03/24 | 39.91 on 05/30/24 |
| High | 1,017.34 on 06/12/24 | 321.44 on 05/15/24 | 486.42 on 06/07/24 | 45.92 on 05/15/24 | 45.72 on 05/14/24 |
| 3-Month | |||||
| %Chg | +4.37% since 03/12/24 | +9.20% since 03/12/24 | +16.02% since 03/12/24 | -5.10% since 03/12/24 | -22.23% since 03/12/24 |
| Low | 875.22 on 04/26/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 39.15 on 04/18/24 | 39.91 on 05/30/24 |
| High | 1,017.34 on 06/12/24 | 322.60 on 05/03/24 | 486.42 on 06/07/24 | 45.92 on 05/15/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | +17.28% since 12/12/23 | +10.22% since 12/12/23 | +33.76% since 12/12/23 | +12.75% since 12/12/23 | -16.24% since 12/12/23 |
| Low | 838.46 on 12/21/23 | 260.68 on 04/19/24 | 372.80 on 12/13/23 | 35.87 on 12/15/23 | 39.91 on 05/30/24 |
| High | 1,017.34 on 06/12/24 | 329.72 on 02/05/24 | 486.42 on 06/07/24 | 45.92 on 05/15/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 111,347,352 | 161,306,016 | 124,260,272 | 85,094,392 | 87,205,840 |
| Shares Outstanding, K | 110,186 | 536,435 | 258,053 | 2,072,440 | 2,027,100 |
| Annual Sales | 13,117,200,000 | 28,190,000,000 | 9,869,200,000 | 37,725,000,000 | 45,006,000,000 |
| Annual Net Income | 3,953,600,000 | 6,717,000,000 | 3,619,600,000 | 6,129,940,000 | 8,025,000,000 |
| Last Quarter Sales | 3,145,000,000 | 7,447,000,000 | 2,690,600,000 | 9,337,020,000 | 11,865,000,000 |
| Last Quarter Net Income | 722,000,000 | -113,000,000 | 1,099,600,000 | 1,326,430,000 | -11,911,000,000 |
| 60-Month Beta | 0.13 | 0.60 | 0.41 | 0.66 | 0.43 |
| Per-Share Information | |||||
| Most Recent Earnings | 9.55 on 05/02/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 1.09 on 05/01/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 08/01/24 | 08/01/24 | 05/06/24 | 07/24/24 | 07/26/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | 0.369 on 05/16/24 | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | 05/16/24 | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 26.99 | 16.36 | 32.09 | 10.22 | 40.54 |